Médecins pour Adénocarcinome à l'étranger — Page 3

Le Prof. Univ. Dr Wolfgang Köstler est spécialisé dans les cancers du sein et gynécologiques, avec plus de deux décennies d'expertise dans les thérapies ciblées et la médecine personnalisée.

• Professeur associé à l'Université de médecine de Vienne
• Chef adjoint de la division clinique d'oncologie
• Se concentrer sur le développement de biomarqueurs et la biologie tumorale
• Consultant senior à la Wiener Privatklinik

Le Dr Fox dirige la clinique d'hématologie, d'oncologie et de médecine palliative du BKZ Solingen – un centre d'oncologie interdisciplinaire certifié.

• Se spécialiser en chimiothérapie, immunothérapie et thérapies ciblées
• Spécialiste qualifié en génétique depuis 2016
• Être actif dans la recherche en biologie moléculaire pour les traitements contre le cancer
• Membre de sociétés d'oncologie allemandes et américaines
• Expérience de médecin-chef adjoint depuis 2011

Spécialisé dans les cancers du sein, du poumon et gastro-intestinaux, le Dr Ozatli apporte une approche ciblée au traitement de l'adénocarcinome à l'hôpital universitaire Istinye Liv.

• Professeur associé depuis 2016
• Expérience dans plusieurs services d'oncologie en Turquie
• Formation à la faculté de médecine de l'université de Selcuk

Le professeur Keil est spécialisé en radiologie diagnostique et interventionnelle, utilisant des techniques d'imagerie avancées pour la détection et le traitement précis de l'adénocarcinome.

• Diplômé avec mention de l'Université Julius-Maximilian de Wurtzbourg
• Formé auprès du célèbre professeur Rolf W. Günther à l'Hôpital Universitaire d'Aix-la-Chapelle
• Expert en IRM, scanner et échographie pour les interventions complexes
• Médecin-chef à l'Hôpital Académique de Solingen depuis 2022

Spécialiste en virothérapie – l'un des domaines les plus récents de l'immunologie. Le Dr Jaunalksne apporte plus de 30 ans d'expérience à la Pallas Clinic.

• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômée de l'Institut de médecine de Riga
• Internat en médecine interne

Le Dr Séverine Iborra dirige le département de gynécologie et d'obstétrique au Städtisches Klinikum Solingen, se spécialisant en oncologie gynécologique. Son expertise dans les techniques mini-invasives garantit précision et récupération rapide.

• Être certifiée en oncologie gynécologique et en obstétrique spécialisée
• Utiliser la laparoscopie et le système robotique Da Vinci pour la précision chirurgicale
• Être membre actif des principales sociétés allemandes de gynécologie
• Publier de nombreux travaux sur l'oncologie moléculaire et les traitements gynécologiques

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.

Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Le Dr Alemdar est spécialisé en oncologie médicale, ayant suivi une formation approfondie à l'université d'Akdeniz, un leader des soins oncologiques.

• Certifié en oncologie médicale depuis 2018
• Soigner des patients au complexe hospitalier Medical Park Antalya
• Plus d'une décennie d'expérience en médecine interne et en oncologie

Dr. Mariam Abu Zeid is a clinical oncologist at Shefaa Al Orman International Oncology Hospitals. She is certified by the European Society for Medical Oncology. Dr. Abu Zeid treats solid tumors and hematologic cancers. She holds a Ph.D. in Clinical Oncology and Nuclear Medicine from Ain Shams University.

• Administers chemotherapy, immunotherapy, and targeted treatments for various cancer types.
• Oversees oncology clinical trials and manages treatment-related toxicities.
• Coordinates patient care within multidisciplinary teams for complex staging and diagnosis.
• Practices at an ESMO-accredited center that treats approximately 6,000 patients annually.

Expert en chirurgie thoracique mini-invasive et robotique – Le Dr Dobritoiu utilise de petites incisions pour une récupération plus rapide à l'hôpital académique Ponderas.

• Se spécialiser en chirurgie thoracique robotique assistée par da Vinci Xi
• Réaliser des chirurgies thoracoscopiques vidéo-assistées (VATS) avec technique uniportale
• Pratiquer des résections pulmonaires et médiastinales complexes avec un drainage minimal
• Être qualifié pour les procédures de médiastinoscopie et de bronchoscopie

Le Dr Muzaffer Al apporte plus de 20 ans d'expérience chirurgicale, avec une formation spécialisée en chirurgie laparoscopique et oncologique.

• Certifié avec une formation avancée provenant des meilleures institutions turques
• Se spécialiser dans les procédures laparoscopiques antireflux et bariatriques
• Se concentrer sur les techniques chirurgicales minimalement invasives pour le cancer

Professor Zheng Qiu Hong is Director of the Cell Therapy Research Center and a National Senior Expert in Biotherapy. He is a Professor and Master’s Supervisor at Fujian Medical University. He has more than 30 years of clinical experience in tumor molecular biology and biotherapy. From 2012 to 2013, he was a visiting scholar in stem cell research at the University of Connecticut School of Life Sciences. He previously held leadership roles at Fujian Cancer Hospital. These roles included Director of the Tumor Molecular Biology Laboratory and Director of the Surgical Oncology Research Laboratory. He also served as Deputy Director of the Fujian Key Laboratory of Tumor Biotherapy and Deputy Director of the Biotherapy and Immunotherapy Center.

Appointments include Standing Committee Member of the Biotherapy Committee of the Chinese Research Hospital Association. He is also a Committee Member of the Tumor Immunology and Biotherapy Committee of the Chinese Society for Immunology. In addition, he is Deputy Chair of the Academic Committee of the Xiamen Cell Therapy Research Center at the First Affiliated Hospital of Xiamen University.

Dr. Mohamed Mahmoud Abdelhakim is a Professor of Radiation Oncology at Cairo University’s National Cancer Institute. He serves as the Head of Radiation Oncology at Shefa al Orman Hospital. Dr. Abdelhakim treats complex cancers, including breast, soft tissue sarcoma, and gynecologic tumors. He is a member of ESTRO and ESMO.

• Performs image-guided brachytherapy and stereotactic radiotherapy.
• Uses IMRT, VMAT, SRS, and SBRT for precise tumor targeting.
• Provides total body and total skin irradiation for bone marrow transplants.
• Practices at ESMO-accredited Shefa al Orman Hospital in Luxor.

Dr. Maha Yahia is a medical and hemato-oncologist at Shefaa Al Orman International Oncology Hospitals. She served as a Lieutenant Colonel physician in the Egyptian Armed Forces Medical Corps. Dr. Yahia specializes in treatment planning for breast, thoracic, and gastrointestinal cancers. She focuses on immunotherapy, targeted therapy, and complex chemotherapy protocols.

• Former Head of the Clinical Research Support Team at Maadi AFMC.
• Trained at the National Cancer Institute, Cairo University, in hemato-oncology.
• Treats genitourinary, gynecologic, and rare cancers alongside hematologic conditions.
• Works at an ESMO-accredited center that treats 6,000 patients annually.

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dirige l'ensemble du centre d'oncologie en tant que médecin chef au centre médical Assuta.

• Se spécialiser en oncologie médicale et en traitement du cancer
• Posséder une vaste expérience dans la gestion de cas de cancer complexes
• Superviser les soins aux patients et les protocoles d'un service d'oncologie de premier plan